Clinical trials in Zabrze – page 42

1 174 clinical trials in Zabrze, Poland across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Zabrze at a glance

1 174

clinical trials

Research sites3

Quick filters

1 174 trials in Zabrze

Open in trial search

Systemic lupus erythematosus+1

Not yet recruiting

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:CC-97540
Sponsor:Celgene Corp.

Contact Research Centre

Bronchiectasis

Not yet recruiting

Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

Investigational

Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:CSL Behring LLC

Contact Research Centre

Rhinitis+2

Not yet recruiting

Study of Actisoufre nasal spray containing sodium sulfide and saccharomyces extract for adults and children over 6 years with acute rhinitis, rhinopharyngitis, and rhinosinusitis

Registered drug

Study of Actisoufre nasal spray containing sodium sulfide and saccharomyces extract for adults and children over 6 years with acute rhinitis, rhinopharyngitis, and rhinosinusitis

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Saccharomyces cerevisiae type D extract
Sponsor:Laboratoires Grimberg

Contact Research Centre

Colitis ulcerative

Not yet recruiting

Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Study on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Vedolizumab
Sponsor:Odyssey Therapeutics Inc.

Contact Research Centre

Seasonal allergy

Not yet recruiting

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Registered drug

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Probelte Pharma S.L.

Contact Research Centre

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

Investigational

Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Pacibekitug
Sponsor:Tourmaline Bio Inc.

Contact Research Centre

B precursor type acute leukaemia

Not yet recruiting

Study of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia

InvestigationalNo placebo

Study of Tisagenlecleucel for Treating Adult Patients with Resistant or Relapsed B-cell Acute Lymphoblastic Leukemia

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Tisagenlecleucel
Sponsor:Medical University Of Warsaw

Contact Research Centre

Immune-mediated myositis

Not yet recruiting

Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

Registered drugNo placebo

Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Novartis Pharma AG

Contact Research Centre

Cholangitis sclerosing

Not yet recruiting

Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

InvestigationalNo placebo

Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Norucholic Acid
Sponsor:Dr. Falk Pharma GmbH

Contact Research Centre

Atrial fibrillation+1

Not yet recruiting

Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

Registered drug

Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Heparin Sodium
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Colitis ulcerative

Not yet recruiting

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Adalimumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Systemic scleroderma

Not yet recruiting

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Registered drugNo placebo

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Novartis Pharma AG

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Zabrze

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focusing on heart failure treatment and prevention, including studies of novel drug combinations like baxdrostat/dapagliflozin and sacubitril/valsartan. Research encompasses various cardiac conditions, from post-myocardial infarction care to atrial fibrillation management.

Heart Failure Prevention
Cardiomyopathy Treatment
Post-Transplant Care

Multiple studies are examining innovative approaches to cardiac health management and prevention strategies.

02 Neurological Disorders

Advanced clinical research in multiple sclerosis treatments, testing new therapies like frexalimab and ublituximab. Studies also include innovative approaches to treating Alzheimer's disease and chronic inflammatory demyelinating polyneuropathy.

Multiple Sclerosis Management
Dementia Treatment
Neuropathy Research

Trials focus on improving patient outcomes and developing more effective treatment protocols.

03 Metabolic Conditions

Comprehensive studies addressing obesity management and diabetes control, particularly in adolescent populations. Research includes evaluation of new treatments like tirzepatide and innovative insulin therapies.

Weight Management
Type 2 Diabetes
Growth Disorders

Research aims to develop more effective treatments for metabolic disorders across different age groups.

Back to Poland All countries